AIM2は,細胞プラズマのDNAに反応して,炎症体と細胞死を活性化します
Teresa Fernandes-Alnemri1, Je-Wook Yu, Pinaki Datta
1Department of Biochemistry and Molecular Biology, Center for Apoptosis Research, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Nature
|January 23, 2009
まとめ
メラノーマ2 (AIM2) に欠けていた炎症ゾームは,細胞質DNAを感知し,カスパース-1とピロプトーシスを活性化します. この発見は,AIM2を明らかにしています.
科学分野:
- 免疫学 免疫学とは
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- 宿主または病原体からの細胞質の二重鎖DNAは炎症体を活性化します.
- インフラマソームの活性化は,カスパーゼ-1の活性化とプロインタールイキン-1βの成熟につながります.
- インフラマソームの活性化における細胞質DNAの特定のセンサーは,未確認のままでした.
研究 の 目的:
- 細胞プラズマのDNAが誘発する炎症細胞の活性化に責任のあるセンサータンパク質を特定する.
- 細胞質DNAが炎症体を活性化するメカニズムを解明する.
- インフラマソームとピロプトソーム形成におけるAIM2の役割を特徴づける.
主な方法:
- マクロファージにおけるAIM2発現をノックダウンするために,短い干渉RNA (siRNA) を利用した.
- 細胞質DNAへの反応として,炎症体とピロプトソームの活性化を評価した.
- 反応しない細胞系 (HEK293T) でAIM2を表現して,誘発反応性をテストします.
主要な成果:
- メラノーマ2 (AIM2) の欠席は,細胞質DNAセンサーとして識別されました.
- AIM2のオリゴヌクレオチド/オリゴサカライド結合ドメイン (OB) はDNAを感知し,ピリンドメインはASCと相互作用する.
- AIM2の活性化により,ASCのピロプトソーム形成,カスパーゼ1の活性化,そしてピロプト細胞死が発生する.
結論:
- AIM2は,細胞質DNAを検出する炎症体の重要な構成要素です.
- AIM2のオリゴメリゼーションは,細胞質DNAによって誘発され,炎症ゾームの組み立てを開始します.
- AIM2-ASCの相互作用は,カスパーゼ-1の活性化とピロプトーシスを誘発し,これは重要な先天性免疫反応である.
関連する概念動画
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...


